Press Releases from DelveInsight Business Research (5349 total)
Hemophilia A Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …
Hemophilia A companies are Spark Therapeutics, Sigilon Therapeutics, ASC Therapeutics, Pfizer, Sanofi Genzyme, Novo Nordisk, Hoffmann-La Roche, Chugai Pharmaceutical, Shire, Pfizer, BioMarin Pharmaceutical, Sinocelltech Ltd,…
Ascites Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, M …
(Albany, United States) As per DelveInsight's assessment, globally, Ascites pipeline constitutes 10+ key companies continuously working towards developing 10+ Ascites treatment therapies, analysis of Clinical…
Genital Warts Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therap …
(Albany, United States) As per DelveInsight's assessment, globally, Genital Warts pipeline constitutes 30+ key companies continuously working towards developing 30+ Genital Warts treatment therapies, analysis…
Giant-Cell Arteritis Clinical Trials 2024: FDA Approvals, Medication, Therapies, …
(Albany, United States) As per DelveInsight's assessment, globally, Giant-Cell Arteritis pipeline constitutes 6+ key companies continuously working towards developing 6+ Giant-Cell Arteritis treatment therapies, analysis…
Mydriasis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Mydriasis pipeline constitutes 3+ key companies continuously working towards developing 3+ Mydriasis treatment therapies, analysis…
Nasal Polyposis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
(Albany, United States) As per DelveInsight's assessment, globally, Nasal Polyposis pipeline constitutes 4+ key companies continuously working towards developing 4+ Nasal Polyposis treatment therapies, analysis…
Aplastic Anemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Pipeline, Medica …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Aplastic Anemia pipeline constitutes 5+ key companies continuously working towards developing 8+ Aplastic Anemia treatment…
Eosinophilic Esophagitis Clinical Trials 2024: FDA Approvals, Medication, Therap …
(Albany, USA) DelveInsight's, "Eosinophilic Esophagitis Pipeline Insight 2024" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Eosinophilic Esophagitis pipeline landscape.…
Essential Thrombocythemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medica …
(Albany, United States) As per DelveInsight's assessment, globally, Essential Thrombocythemia pipeline constitutes 6+ key companies continuously working towards developing 6+ Essential Thrombocythemia treatment therapies, analysis…
IgA nephropathy Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
IgA nephropathy companies are Chinook Therapeutics, Inc., RemeGen Co., Ltd., Novartis, Jiangsu HengRui Medicine Co., Ltd., Ionis Pharmaceuticals, Inc., Vera Therapeutics, Inc., Eledon Pharmaceuticals, Guangdong…
C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Clinical Trials 2024: FDA Appro …
(Albany, USA) DelveInsight's, "C-Met Mutated Non-Small Cell Lung Cancer (NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in…
Candidemia Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline, …
(Albany, United States) As per DelveInsight's assessment, globally, Candidemia pipeline constitutes 4+ key companies continuously working towards developing 4+ Candidemia treatment therapies, analysis of Clinical…
CAR T-Cell Therapy for Non-Hodgkin's lymphoma Pipeline Analysis 2024: EMA, PDMA, …
(Albany, United States) As per DelveInsight's assessment, globally, CAR T-Cell Therapy for Non-Hodgkin's lymphoma pipeline constitutes 5+ key companies continuously working towards developing 5+ CAR…
Cystinosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapies …
(Albany, USA) DelveInsight's 'Cystinosis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Cystinosis therapies in various stages of clinical development,…
Dermatomyositis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Ther …
Dermatomyositis companies are Kezar Life Sciences, Argenx, Pfizer, CSL Behring, Viela Bio, PAEAN Biotechnology, Alexion Pharmaceuticals, others.
(Albany, United States) As per DelveInsight's assessment, globally, Dermatomyositis…
Diabetic Kidney Disease Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicati …
(Albany, United States) As per DelveInsight's assessment, globally, Diabetic Kidney Disease pipeline constitutes key companies continuously working towards developing Diabetic Kidney Disease treatment therapies, analysis…
Diabetic Macular Edema Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, USA) DelveInsight's, "Diabetic Macular Edema Pipeline Insight 2024" report provides comprehensive insights about 60+ Diabetic Macular Edema companies and 65+ Diabetic Macular Edema pipeline…
Glioblastoma Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Therapi …
(Albany, USA) As per DelveInsight's assessment, globally, Glioblastoma pipeline constitutes 190+ key companies continuously working towards developing 200+ Glioblastoma treatment therapies, analysis of Clinical Trials,…
Hematopoietic Stem Cell Transplantation Clinical Trials 2024: EMA, PDMA, FDA App …
(Albany, United States) As per DelveInsight's assessment, globally, Hematopoietic Stem Cell Transplantation pipeline constitutes 20+ key companies continuously working towards developing 20+ Hematopoietic Stem Cell…
Lupus Nephritis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Trea …
(Albany, USA) As per DelveInsight's assessment, globally, about 30+ key pharma and biotech companies are working on 35+ pipeline drugs in the Lupus Nephritis therapeutics…
Metastatic Colorectal Cancer Clinical Trials 2024: EMA, PDMA, FDA Approvals, Med …
(Albany, United States) As per DelveInsight's assessment, globally, Metastatic Colorectal Cancer pipeline constitutes 80+ key companies continuously working towards developing 100+ Metastatic Colorectal Cancer treatment…
Multiple Sclerosis Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …
(Albany, USA) DelveInsight's, "Multiple Sclerosis Pipeline Insight" report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Multiple sclerosis pipeline landscape. It…
Spinal Cord Injury Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, T …
(Albany, United States) As per DelveInsight's assessment, globally, Spinal Cord Injury pipeline constitutes 35+ key companies continuously working towards developing 35+ Spinal Cord Injury treatment…
Tenosynovial Giant Cell Tumors Clinical Trials 2024: EMA, PDMA, FDA Approvals, M …
(Albany, United States) As per DelveInsight's assessment, globally, Tenosynovial Giant Cell Tumors pipeline constitutes 5+ key companies continuously working towards developing 5+ Tenosynovial Giant Cell…
Traumatic Brain Injury Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medicatio …
(Albany, United States) As per DelveInsight's assessment, globally, Traumatic Brain Injury pipeline constitutes key companies continuously working towards developing Traumatic Brain Injury treatment therapies, analysis…
Ulcerative Colitis Clinical Trials and Pipeline 2024: FDA Approvals, Medication, …
(Albany, USA) DelveInsight's 'Ulcerative Colitis Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Ulcerative Colitis therapies in various stages of…
Vitiligo Clinical Trials and Pipeline 2024: FDA Approvals, Medication, Treatment …
(Nevada, United States) As per DelveInsight's assessment, globally, Vitiligo pipeline constitutes 22+ key companies continuously working towards developing 22+ Vitiligo treatment therapies, analysis of Clinical…
Atopic Dermatitis Clinical Trials and Pipeline 2024: FDA Approvals, Medication, …
(Albany, United States) As per DelveInsight's assessment, globally, Atopic Dermatitis pipeline constitutes 100+ key companies continuously working towards developing 110+ Atopic Dermatitis treatment therapies, analysis…
Autosomal Dominant Polycystic Kidney Disease (AKPKD) Clinical Trials 2024: FDA A …
(Albany, United States) As per DelveInsight's assessment, globally, Autosomal Dominant Polycystic Kidney Disease pipeline constitutes 12+ key companies continuously working towards developing 12+ Autosomal Dominant…
Axillary Hyperhidrosis Clinical Trials 2024: FDA Approvals, Medication, Treatmen …
DelveInsight's, "Axillary Hyperhidrosis Pipeline Insight 2024" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Axillary Hyperhidrosis pipeline landscape. It covers the…
Diabetic Retinopathy Clinical Trials 2024: FDA Approvals, Medication, Treatment …
(Albany, USA) DelveInsight's, "Diabetic Retinopathy Pipeline Insight 2024" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in the Diabetic Retinopathy pipeline landscape.…
Ewing Sarcoma Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, …
(Albany, USA) Ewing Sarcoma pipeline constitutes 25+ key companies continuously working towards developing 25+ Ewing Sarcoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of…
Exosomes Clinical Trials 2024: FDA Approvals, Medication, Treatment Market, Ther …
(Albany, USA) DelveInsight's 'Exosomes Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline exosomes-based therapies in various stages of clinical development,…
Leptomeningeal Metastases Clinical Trials 2024: FDA Approvals, Medication, Treat …
(Albany, United States) As per DelveInsight's assessment, globally, Leptomeningeal Metastases pipeline constitutes 5+ key companies continuously working towards developing 5+ Leptomeningeal Metastases treatment therapies, analysis…
Liver Cirrhosis Clinical Trials 2024: FDA Approvals, Medication, Treatment Marke …
(Albany, USA) DelveInsight's, "Liver Cirrhosis Pipeline Insight 2024" report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Liver Cirrhosis pipeline landscape. It…
Major Depressive Disorder Clinical Trials 2024: FDA Approvals, Medication, Treat …
(Albany, USA) DelveInsight's, "Major Depressive Disorder Pipeline Insight" report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline…
Paroxysmal Nocturnal Hemoglobinuria Clinical Trials 2024: FDA Approvals, Medicat …
(Albany, USA) DelveInsight's, "Paroxysmal Nocturnal Haemoglobinuria Pipeline Insight 2024" report provides comprehensive insights about 20+ companies and 25+ pipeline drugs in Paroxysmal Nocturnal Haemoglobinuria pipeline…
PCSK9 Inhibitors Clinical Trials 2024: FDA Approvals, Medication, Treatment Mark …
(Nevada, United States) As per DelveInsight's assessment, globally, PCSK9 Inhibitors pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitors treatment therapies, analysis…
PD-1 Non-Small Cell Lung Cancer Clinical Trials 2024: FDA Approvals, Medication, …
(Albany, USA) DelveInsight's 'PD-1 Non-Small Cell Lung Cancer Pipeline Insight 2024' report provides comprehensive global coverage of pipeline PD-1 non-small cell lung cancer therapies in…
Respiratory Syncytial Virus Clinical Trials 2024: FDA Approvals, Medication, Tre …
(Nevada, United States) As per DelveInsight's assessment, globally, Respiratory Syncytial Virus pipeline constitutes 50+ key companies continuously working towards developing 50+ Respiratory Syncytial Virus treatment…
Retinitis Pigmentosa Clinical Trials 2024: FDA Approvals, Medication, Therapies, …
(Albany, USA) DelveInsight's, "Retinitis Pigmentosa Pipeline Insight 2024" report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Retinitis Pigmentosa pipeline landscape. It…
Schizophrenia Clinical Trials 2024: FDA Approvals, Medication, Therapies, Treatm …
(Albany, USA) DelveInsight's 'Schizophrenia Pipeline Insight 2024' report provides comprehensive global coverage of available, marketed, and pipeline Schizophrenia therapies in various stages of clinical development,…
Urothelial Carcinoma Clinical Trials 2024: FDA Approvals, Medication, Therapies, …
(Albany, United States) DelveInsight's, "Urothelial Carcinoma Pipeline Insight 2024" report provides comprehensive insights about 40+ Urothelial Carcinoma companies and 50+ pipeline drugs in the Urothelial…
Uveitis Clinical Trials 2024: FDA Approvals, Medication, Therapies, Treatment Ma …
(Nevada, United States) As per DelveInsight's assessment, globally, Uveitis pipeline constitutes 15+ key companies continuously working towards developing 15+ Uveitis treatment therapies, analysis of Clinical…
X-Linked Retinitis Pigmentosa Clinical Trials 2024: FDA Approvals, Medication, T …
(Albany, United States) As per DelveInsight's assessment, globally, the X-Linked Retinitis Pigmentosa Pipeline constitutes 5+ key companies continuously working towards developing 5+ X-Linked Retinitis Pigmentosa…
Rosacea Clinical Trials 2024: EMA, PDMA, FDA Approvals, Medication, Pipeline The …
(Albany, United States) As per DelveInsight's assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Rosacea therapeutics…
Obsessive Compulsive Disorder Pipeline Analysis 2024: FDA Approvals, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Obsessive Compulsive Disorder pipeline constitutes 5+ key companies continuously working towards developing 5+ Obsessive Compulsive…
ALK-positive Non-Small Cell Lung Cancer Clinical trials 2024: EMA, PDMA, FDA App …
DelveInsight's, "ALK-positive Non-Small Cell Lung Cancer (ALK+ NSCLC) Pipeline Insight 2024" report provides comprehensive insights about 6+ companies and 7+ pipeline drugs in ALK-positive Non-Small…
Anorexia Nervosa Clinical trials 2024: EMA, PDMA, FDA Approvals, Medication, The …
As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on various pipeline therapies in the Anorexia Nervosa therapeutics landscape based on…
Benign Breast Disease and Early Breast Cancer Drugs Market 2034: Clinical Trials …
(Albany, USA) DelveInsight's "Benign Breast Disease and Early Breast Cancer Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Benign Breast…
